244 related articles for article (PubMed ID: 30796591)
1. Comprehensive validation of the functional assessment of anorexia/cachexia therapy (FAACT) anorexia/cachexia subscale (A/CS) in lung cancer patients with involuntary weight loss.
Gelhorn HL; Gries KS; Speck RM; Duus EM; Bourne RK; Aggarwal D; Cella D
Qual Life Res; 2019 Jun; 28(6):1641-1653. PubMed ID: 30796591
[TBL] [Abstract][Full Text] [Related]
2. Brief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia.
Salsman JM; Beaumont JL; Wortman K; Yan Y; Friend J; Cella D
Support Care Cancer; 2015 May; 23(5):1355-64. PubMed ID: 25351456
[TBL] [Abstract][Full Text] [Related]
3. Quality of life and anorexia/cachexia in lung cancer: validation of the Spanish version of the FAACT instrument.
Arrieta O; Luvián-Morales J; Turcott JG; Oñate-Ocaña LF
Qual Life Res; 2018 Oct; 27(10):2709-2718. PubMed ID: 29987501
[TBL] [Abstract][Full Text] [Related]
4. Validation and real-world assessment of the Functional Assessment of Anorexia-Cachexia Therapy (FAACT) scale in patients with advanced non-small cell lung cancer and the cancer anorexia-cachexia syndrome (CACS).
LeBlanc TW; Samsa GP; Wolf SP; Locke SC; Cella DF; Abernethy AP
Support Care Cancer; 2015 Aug; 23(8):2341-7. PubMed ID: 25586527
[TBL] [Abstract][Full Text] [Related]
5. Re-validation and shortening of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaire.
Ribaudo JM; Cella D; Hahn EA; Lloyd SR; Tchekmedyian NS; Von Roenn J; Leslie WT
Qual Life Res; 2000; 9(10):1137-46. PubMed ID: 11401046
[TBL] [Abstract][Full Text] [Related]
6. FAACT-Anorexia Cachexia Scale: Cutoff Value for Anorexia Diagnosis in Advanced Non-Small Cell Lung Cancer Patients.
Turcott JG; Oñate-Ocaña LF; Soca-Chafre G; Ramírez-Tirado LA; Flores-Estrada D; Zatarain-Barrón ZL; Arrieta O
Nutr Cancer; 2019; 71(3):409-417. PubMed ID: 30273069
[TBL] [Abstract][Full Text] [Related]
7. The Functional Assessment of Anorexia/Cachexia Therapy (FAACT) Appetite Scale in veteran cancer patients.
Chang VT; Xia Q; Kasimis B
J Support Oncol; 2005; 3(5):377-82. PubMed ID: 16218262
[TBL] [Abstract][Full Text] [Related]
8. Anorexia/cachexia-related quality of life for children with cancer.
Lai JS; Cella D; Peterman A; Barocas J; Goldman S
Cancer; 2005 Oct; 104(7):1531-9. PubMed ID: 16088963
[TBL] [Abstract][Full Text] [Related]
9. Validation of the Chinese version of functional assessment of anorexia-cachexia therapy (FAACT) scale for measuring quality of life in cancer patients with cachexia.
Zhou T; Yang K; Thapa S; Fu Q; Jiang Y; Yu S
Support Care Cancer; 2017 Apr; 25(4):1183-1189. PubMed ID: 27900546
[TBL] [Abstract][Full Text] [Related]
10. Validation of the functional assessment of anorexia/cachexia therapy instrument to assess quality of life in maintenance hemodialysis patients with cachexia.
Yang Z; Luo Y; Lu H; Zou B; Wang H; Chen G; Wu Y; Huang Y
Semin Dial; 2022 Jul; 35(4):330-336. PubMed ID: 35032061
[TBL] [Abstract][Full Text] [Related]
11. Early recognition of anorexia through patient-generated assessment predicts survival in patients with oesophagogastric cancer.
Abraham M; Kordatou Z; Barriuso J; Lamarca A; Weaver JMJ; Cipriano C; Papaxoinis G; Backen A; Mansoor W
PLoS One; 2019; 14(11):e0224540. PubMed ID: 31774822
[TBL] [Abstract][Full Text] [Related]
12. Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study.
Takayama K; Atagi S; Imamura F; Tanaka H; Minato K; Harada T; Katakami N; Yokoyama T; Yoshimori K; Takiguchi Y; Hataji O; Takeda Y; Aoe K; Kim YH; Yokota S; Tabeta H; Tomii K; Ohashi Y; Eguchi K; Watanabe K
Support Care Cancer; 2016 Aug; 24(8):3473-80. PubMed ID: 27003901
[TBL] [Abstract][Full Text] [Related]
13. Cancer Anorexia and Cachexia: Screening in an Ambulatory Infusion Service and Nutrition Consultation
.
Berry DL; Blonquist T; Nayak MM; Roper K; Hilton N; Lombard H; Hester A; Chiavacci A; Meyers S; McManus K
Clin J Oncol Nurs; 2018 Feb; 22(1):63-68. PubMed ID: 29350696
[TBL] [Abstract][Full Text] [Related]
14. Staging of nutrition disorders in non-small-cell lung cancer patients: utility of skeletal muscle mass assessment.
Antoun S; Morel H; Souquet PJ; Surmont V; Planchard D; Bonnetain F; Foucher P; Egenod T; Krakowski I; Gaudin H; Debieuvre D
J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):782-793. PubMed ID: 30932365
[TBL] [Abstract][Full Text] [Related]
15. Asprosin is associated with anorexia and body fat mass in cancer patients.
Du C; Wang C; Guan X; Li J; Du X; Xu Z; Li B; Liu Y; Fu F; Huo H; Zheng Z
Support Care Cancer; 2021 Mar; 29(3):1369-1375. PubMed ID: 32661697
[TBL] [Abstract][Full Text] [Related]
16. Post-diagnosis weight loss as a prognostic factor in non-small cell lung cancer.
Mytelka DS; Li L; Benoit K
J Cachexia Sarcopenia Muscle; 2018 Feb; 9(1):86-92. PubMed ID: 29205930
[TBL] [Abstract][Full Text] [Related]
17. Updates on the pathogenesis of advanced lung cancer-induced cachexia.
Zhu R; Liu Z; Jiao R; Zhang C; Yu Q; Han S; Duan Z
Thorac Cancer; 2019 Jan; 10(1):8-16. PubMed ID: 30461213
[TBL] [Abstract][Full Text] [Related]
18. The assessment of anorexia in patients with cancer: cut-off values for the FAACT-A/CS and the VAS for appetite.
Blauwhoff-Buskermolen S; Ruijgrok C; Ostelo RW; de Vet HCW; Verheul HMW; de van der Schueren MAE; Langius JAE
Support Care Cancer; 2016 Feb; 24(2):661-666. PubMed ID: 26160463
[TBL] [Abstract][Full Text] [Related]
19. Erlotinib plus parenteral nutrition: an opportunity to get through the hardest days of advanced non-small cell lung cancer with cancer anorexia-cachexia syndrome.
Zang YS; Fang Z; Li B
Am J Hosp Palliat Care; 2013 Mar; 30(2):210-3. PubMed ID: 23393267
[TBL] [Abstract][Full Text] [Related]
20. A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in patients with cancer cachexia and low body mass index.
Naito T; Uchino J; Kojima T; Matano Y; Minato K; Tanaka K; Mizukami T; Atagi S; Higashiguchi T; Muro K; Takayama K; Furuse J; Morishima E; Takiguchi T; Tamura K
Cancer; 2022 May; 128(10):2025-2035. PubMed ID: 35195274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
